According to CNBC Pro’s analysis, nine stocks around the world have raised their dividends every year over the past three decades. High inflation has sapped the purchasing power of investors who rely on dividend payments as a source of income over the past year. However, in companies that have consistently increased their payout ratios, investors will typically see their total returns align with price increases throughout the investment period. Of the approximately 92,000 global stocks screened by CNBC Pro, the following nine consistently reward their shareholders. Fortis Canada Fortis has increased the dividend payout to shareholders every year since 1993. The 138-year-old company boosted its dividend per share by 5.9% in 2022, and currently yields 3.9%. Shares of the electric and gas utility, which serves 3.4 million customers, are up 6.37% this year. Earlier this month, as part of its first-quarter earnings, the company also said it would raise its dividend by 4% to 6% through 2027. % over the next 12 months, Maurice Choy, an analyst at investment bank RBC Capital, said in a May 3 note to clients. Novartis Swiss drugmaker Novartis has raised dividend payments since 1991. Novartis stock has been trending higher lately — up 8.9% year-to-date — after trading sideways for more than six months. Analysts believe investor sentiment is changing after the company reported positive phase 3 results for its new early-stage breast cancer drug. “We believe Novartis stock has underperformed due to investor ‘look at me first’ behavior,” Stifel analyst Eric Le Berrigaud said in a note to clients on April 26. Strong skepticism is fading.” . “Not only has the group recently reported good news on the product front … but the financials are now in the same good shape.” Novartis’ dividend yield currently stands at 3.5%. NOVNEE-CH 1Y Line Roche Like its peer Novartis, the Basel, Switzerland-based pharmaceutical and diagnostics company offers a 3.3% dividend yield. The company’s stock peaked in December 2021 and is currently trading below those levels. However, analysts are bullish and believe the stock is now undervalued. “Our analysis suggests that Roche shares continue to trade below the value of the company’s ‘listed’ assets,” Berenberg analyst Luisa Hector wrote in a note to clients on May 17. We believe that, given its leading diagnostics, This is unfounded business offering attractive growth, high barriers to entry, strength in the listed pharma business and Roche’s continued pipeline delivery (despite lower peak sales potential),” she added. UK-launched ROG-CH 1Y mountain stocks Cranswick, Sage Group, Spectris, Spirax-Saco, James Halstead and Ireland’s Kerry Group top the list of companies that have increased their dividend payouts over the past 30 years.